OINDP stands for Orally Inhaled and Nasal Drug Products the regulatory category used by the FDA to classify both inhalation products (metered-dose inhalers, dry powder inhalers, nebulizers) and nasal drug products (nasal sprays, nasal aerosols)
Ensure you select needles that come individually packaged and sterilized
Specifically developed for oral use
In some instances, controlled release of an otic agent provided by the formulations or compositions described herein allows for release of an otic agent at concentrations greater than C min for a period of at least 1 day, 3 days, 4 days, 5 days, 6 days, 7 days, 10 days, 14 days, 3 weeks, 1 month, or 6 months
While BPC-157 is often discussed in injectable form, oral tablets are designed to allow for systemic absorption through the digestive tract , potentially targeting both gut health and broader tissue recovery